{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:25:09Z","timestamp":1775064309096,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2022A1515110558, 2023A1515220197"],"award-info":[{"award-number":["2022A1515110558, 2023A1515220197"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2024NSCQ-MSX1146"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX1146"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072349"],"award-info":[{"award-number":["82072349"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Youth Innovation in Future Medicine, Chongqing Medical University","award":["W0031, W0097"],"award-info":[{"award-number":["W0031, W0097"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10096-025-05060-5","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:34:40Z","timestamp":1739878480000},"page":"1089-1097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vitro synergistic effects of mefloquine combined with other antimicrobial agents on carbapenem-resistant Enterobacterales"],"prefix":"10.1007","volume":"44","author":[{"given":"Chunhong","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianglin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqiang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"5060_CR1","doi-asserted-by":"publisher","first-page":"127249","DOI":"10.1016\/j.micres.2022.127249","volume":"266","author":"J Ma","year":"2023","unstructured":"Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z et al (2023) Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res 266:127249. https:\/\/doi.org\/10.1016\/j.micres.2022.127249","journal-title":"Microbiol Res"},{"key":"5060_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s10096-021-04296-1","volume":"40","author":"K Tompkins","year":"2021","unstructured":"Tompkins K, Van Duin D (2021) Treatment for carbapenem-resistant enterobacterales infections: recent advances and future directions. Eur J Clin Microbiol Infect Dis 40:2053\u20132068. https:\/\/doi.org\/10.1007\/s10096-021-04296-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5060_CR3","doi-asserted-by":"publisher","first-page":"e01065","DOI":"10.1128\/AAC.01065-21","volume":"65","author":"A Olsson","year":"2021","unstructured":"Olsson A, Hong M, Al-Farsi H, Giske CG, Lagerb\u00e4ck P, T\u00e4ngd\u00e9n T (2021) Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases. Antimicrob Agents Chemother 65:e01065\u2013e01021. https:\/\/doi.org\/10.1128\/AAC.01065-21","journal-title":"Antimicrob Agents Chemother"},{"key":"5060_CR4","first-page":"165","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC) (2013) Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 62:165\u2013170 MMWR website. http:\/\/www.cdc.gov\/mmwr","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5060_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/cid\/ciw741","volume":"64","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A et al (2017) Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clin Infect Dis 64:257\u2013264. https:\/\/doi.org\/10.1093\/cid\/ciw741","journal-title":"Clin Infect Dis"},{"key":"5060_CR6","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/cid\/ciz824","volume":"69","author":"P Nordmann","year":"2019","unstructured":"Nordmann P, Poirel L (2019) Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. Clin Infect Dis 69:S521\u2013S528. https:\/\/doi.org\/10.1093\/cid\/ciz824","journal-title":"Clin Infect Dis"},{"key":"5060_CR7","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/jama.2015.12480","volume":"314","author":"AY Guh","year":"2015","unstructured":"Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J et al (2015) Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US communities, 2012\u20132013. JAMA 314:1479. https:\/\/doi.org\/10.1001\/jama.2015.12480","journal-title":"JAMA"},{"key":"5060_CR8","doi-asserted-by":"publisher","first-page":"e01882","DOI":"10.1128\/AAC.01882-17","volume":"62","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B et al (2018) Epidemiology of Carbapenem-Resistant Enterobacteriaceae infections: Report from the China CRE Network. Antimicrob Agents Chemother 62:e01882\u2013e01817. https:\/\/doi.org\/10.1128\/AAC.01882-17","journal-title":"Antimicrob Agents Chemother"},{"key":"5060_CR9","doi-asserted-by":"publisher","first-page":"CD011444","DOI":"10.1002\/14651858.CD011444.pub2","volume":"3","author":"R Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Men\u00e9ndez C (2018) Mefloquine for preventing malaria in pregnant women. Cochrane Database Syst Rev 3:CD011444. https:\/\/doi.org\/10.1002\/14651858.CD011444.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"5060_CR10","doi-asserted-by":"publisher","first-page":"e0282099","DOI":"10.1371\/journal.pone.0282099","volume":"18","author":"T Saeheng","year":"2023","unstructured":"Saeheng T, Na-Bangchang K (2023) Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria. PLoS ONE 18:e0282099. https:\/\/doi.org\/10.1371\/journal.pone.0282099","journal-title":"PLoS ONE"},{"key":"5060_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2174\/1568026619666190304124952","volume":"19","author":"A da Silva Ara\u00fajo","year":"2019","unstructured":"da Silva Ara\u00fajo A, Moraes AM, Louren\u00e7o MCS, Pessoa CO, da Silva ET, de Souza MVN (2019) Synthesis and antibacterial activity of mefloquine-based analogs against sensitive and resistant Mycobacterium tuberculosis strains. Curr Top Med Chem 19:683\u2013689. https:\/\/doi.org\/10.2174\/1568026619666190304124952","journal-title":"Curr Top Med Chem"},{"key":"5060_CR12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","volume":"9","author":"MAE-G El-Sayed Ahmed","year":"2020","unstructured":"El-Sayed Ahmed MAE-G, Zhong L-L, Shen C, Yang Y, Doi Y, Tian G-B (2020) Colistin and its role in the era of antibiotic resistance: an extended review (2000\u20132019). Emerg Microbes Infect 9:868\u2013885. https:\/\/doi.org\/10.1080\/22221751.2020.1754133","journal-title":"Emerg Microbes Infect"},{"key":"5060_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1469-0691.2004.01043.x","volume":"11","author":"AS Michalopoulos","year":"2005","unstructured":"Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME (2005) Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis 11:115\u2013121. https:\/\/doi.org\/10.1111\/j.1469-0691.2004.01043.x","journal-title":"Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"5060_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1185\/03007995.2015.1018989","volume":"31","author":"AZ Bialvaei","year":"2015","unstructured":"Bialvaei AZ, Samadi Kafil H (2015) Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin 31:707\u2013721. https:\/\/doi.org\/10.1185\/03007995.2015.1018989","journal-title":"Curr Med Res Opin"},{"key":"5060_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.33073\/pjm-2019-055","volume":"68","author":"EM Stefaniuk","year":"2019","unstructured":"Stefaniuk EM, Tyski S (2019) Colistin Resistance in Enterobacterales strains\u2013 A current view. Pol J Microbiol 68:417\u2013427. https:\/\/doi.org\/10.33073\/pjm-2019-055","journal-title":"Pol J Microbiol"},{"key":"5060_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"Y-Y Liu","year":"2016","unstructured":"Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J et al (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161\u2013168. https:\/\/doi.org\/10.1016\/S1473-3099(15)00424-7","journal-title":"Lancet Infect Dis"},{"key":"5060_CR17","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s11033-021-06307-y","volume":"48","author":"NH Hussein","year":"2021","unstructured":"Hussein NH, AL-Kadmy IMS, Taha BM, Hussein JD (2021) Mobilized colistin resistance (mcr) genes from 1 to 10: a comprehensive review. Mol Biol Rep 48:2897\u20132907. https:\/\/doi.org\/10.1007\/s11033-021-06307-y","journal-title":"Mol Biol Rep"},{"key":"5060_CR18","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1093\/jac\/dkaa205","volume":"75","author":"Z Ling","year":"2020","unstructured":"Ling Z, Yin W, Shen Z, Wang Y, Shen J, Walsh TR (2020) Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9. J Antimicrob Chemother 75:3087\u20133095. https:\/\/doi.org\/10.1093\/jac\/dkaa205","journal-title":"J Antimicrob Chemother"},{"key":"5060_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"A Ordooei Javan","year":"2015","unstructured":"Ordooei Javan A, Shokouhi S, Sahraei Z (2015) A review on colistin nephrotoxicity. Eur J Clin Pharmacol 71:801\u2013810. https:\/\/doi.org\/10.1007\/s00228-015-1865-4","journal-title":"Eur J Clin Pharmacol"},{"key":"5060_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/d41586-024-02601-4","volume":"632","author":"A Dance","year":"2024","unstructured":"Dance A (2024) Five ways science is tackling the antibiotic resistance crisis. Nature 632:494\u2013496. https:\/\/doi.org\/10.1038\/d41586-024-02601-4","journal-title":"Nature"},{"key":"5060_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s15010-023-02108-6","volume":"52","author":"J Chen","year":"2024","unstructured":"Chen J, Hu Q, Zhou P, Deng S (2024) Ceftazidime\u2013avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. Infection 52:19\u201328. https:\/\/doi.org\/10.1007\/s15010-023-02108-6","journal-title":"Infection"},{"key":"5060_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","volume":"78","author":"GG Zhanel","year":"2018","unstructured":"Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M et al (2018) Imipenem\u2013Relebactam and Meropenem\u2013Vaborbactam: two Novel Carbapenem-\u03b2-Lactamase inhibitor combinations. Drugs 78:65\u201398. https:\/\/doi.org\/10.1007\/s40265-017-0851-9","journal-title":"Drugs"},{"key":"5060_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1469-0691.2005.01198.x","volume":"11","author":"N Petrosillo","year":"2005","unstructured":"Petrosillo N, Chinello P, Proietti MF, Cecchini L, Masala M, Franchi C et al (2005) Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis 11:682\u2013683. https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01198.x","journal-title":"Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"5060_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14787210.2023.2184346","volume":"21","author":"A Ardebili","year":"2023","unstructured":"Ardebili A, Izanloo A, Rastegar M (2023) Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Expert Rev Anti Infect Ther 21:387\u2013429. https:\/\/doi.org\/10.1080\/14787210.2023.2184346","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5060_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acsinfecdis.9b00419","volume":"6","author":"MA Farha","year":"2020","unstructured":"Farha MA, El-Halfawy OM, Gale RT, MacNair CR, Carfrae LA, Zhang X et al (2020) Uncovering the hidden antibiotic potential of Cannabis. ACS Infect Dis 6:338\u2013346. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00419","journal-title":"ACS Infect Dis"},{"key":"5060_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41579-019-0201-x","volume":"17","author":"BW Simpson","year":"2019","unstructured":"Simpson BW, Trent MS (2019) Pushing the envelope: LPS modifications and their consequences. Nat Rev Microbiol 17:403\u2013416. https:\/\/doi.org\/10.1038\/s41579-019-0201-x","journal-title":"Nat Rev Microbiol"},{"key":"5060_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41467-018-02875-z","volume":"9","author":"CR MacNair","year":"2018","unstructured":"MacNair CR, Stokes JM, Carfrae LA, Fiebig-Comyn AA, Coombes BK, Mulvey MR et al (2018) Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nat Commun 9:458. https:\/\/doi.org\/10.1038\/s41467-018-02875-z","journal-title":"Nat Commun"},{"key":"5060_CR28","doi-asserted-by":"publisher","first-page":"e02574","DOI":"10.1128\/AAC.02574-18","volume":"63","author":"R Domalaon","year":"2019","unstructured":"Domalaon R, De Silva PM, Kumar A, Zhanel GG, Schweizer F (2019) The Anthelmintic Drug Niclosamide synergizes with Colistin and reverses Colistin Resistance in Gram-negative Bacilli. Antimicrob Agents Chemother 63:e02574\u2013e02518. https:\/\/doi.org\/10.1128\/AAC.02574-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5060_CR29","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1021\/acsinfecdis.8b00103","volume":"4","author":"BM Minrovic","year":"2019","unstructured":"Minrovic BM, Jung D, Melander RJ, Melander C (2019) A new class of Adjuvants enables lower dosing of Colistin against Acinetobacter baumannii. ACS Infect Dis 4(9):1368\u20131376. https:\/\/doi.org\/10.1021\/acsinfecdis.8b00103","journal-title":"ACS Infect Dis"},{"key":"5060_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.chembiol.2020.04.005","volume":"27","author":"CN Tsai","year":"2020","unstructured":"Tsai CN, MacNair CR, Cao MPT, Perry JN, Magolan J, Brown ED et al (2020) Targeting two-Component systems uncovers a small-molecule inhibitor of Salmonella Virulence. Cell Chem Biol 27:793\u2013805e7. https:\/\/doi.org\/10.1016\/j.chembiol.2020.04.005","journal-title":"Cell Chem Biol"},{"key":"5060_CR31","doi-asserted-by":"publisher","unstructured":"W W, C SH Z, Y D, H W, S P, et al (2021) In Vitro Activity of Auranofin in Combination with Aztreonam-Avibactam against Metallo-\u03b2-lactamase (MBL)-Producing enterobacterales. Front Cell Infect Microbiol 11. https:\/\/doi.org\/10.3389\/fcimb.2021.755763","DOI":"10.3389\/fcimb.2021.755763"},{"key":"5060_CR32","unstructured":"CLSI (2024) Performance standards for antimicrobial susceptibility testing, 34nd ed. CLSI M100. Clinical and Laboratory Standards Institute"},{"key":"5060_CR33","unstructured":"EUCAST (2024) The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, 2024. web page. http:\/\/www.eucast.org"},{"key":"5060_CR34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3389\/fmicb.2018.00721","volume":"9","author":"TB Tran","year":"2018","unstructured":"Tran TB, Wang J, Doi Y, Velkov T, Bergen PJ, Li J (2018) Novel polymyxin combination with Antineoplastic Mitotane improved the bacterial killing against polymyxin-resistant multidrug-resistant gram-negative pathogens. Front Microbiol 9:721. https:\/\/doi.org\/10.3389\/fmicb.2018.00721","journal-title":"Front Microbiol"},{"key":"5060_CR35","unstructured":"M26-A Methods for Determining Bactericidal Activity of Antimicrobia l Agents(1999); Approved Guideline"},{"key":"5060_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jac\/dkm136","volume":"60","author":"JY Song","year":"2007","unstructured":"Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ et al (2007) In vitro activities of carbapenem\/sulbactam combination, colistin, colistin\/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 60:317\u2013322. https:\/\/doi.org\/10.1093\/jac\/dkm136","journal-title":"J Antimicrob Chemother"},{"key":"5060_CR37","unstructured":"World Health Organization, WHO Bacterial Priority Pathogens List (2024) Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance. 1st ed. web page. https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"key":"5060_CR38","doi-asserted-by":"publisher","first-page":"e00079","DOI":"10.1128\/CMR.00079-17","volume":"31","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2018","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Guti\u00e9rrez-Guti\u00e9rrez B, Machuca I, Pascual A (2018) Treatment of infections caused by extended-spectrum-Beta-Lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev 31:e00079\u2013e00017. https:\/\/doi.org\/10.1128\/CMR.00079-17","journal-title":"Clin Microbiol Rev"},{"key":"5060_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/antibiotics8030122","volume":"8","author":"B Suay-Garc\u00eda","year":"2019","unstructured":"Suay-Garc\u00eda B, P\u00e9rez-Gracia MT (2019) Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) infections. Antibiot Basel Switz 8:122. https:\/\/doi.org\/10.3390\/antibiotics8030122","journal-title":"Antibiot Basel Switz"},{"key":"5060_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.drup.2011.02.003","volume":"14","author":"L Freire-Moran","year":"2011","unstructured":"Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, Monnet DL et al (2011) Critical shortage of new antibiotics in development against multidrug-resistant bacteria-time to react is now. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother 14:118\u2013124. https:\/\/doi.org\/10.1016\/j.drup.2011.02.003","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"5060_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","volume":"51","author":"MI Hutchings","year":"2019","unstructured":"Hutchings MI, Truman AW, Wilkinson B (2019) Antibiotics: past, present and future. Curr Opin Microbiol 51:72\u201380. https:\/\/doi.org\/10.1016\/j.mib.2019.10.008","journal-title":"Curr Opin Microbiol"},{"key":"5060_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpddr.2021.06.003","volume":"17","author":"SS Ahmad","year":"2021","unstructured":"Ahmad SS, Rahi M, Ranjan V, Sharma A (2021) Mefloquine as a prophylaxis for malaria needs to be revisited. Int J Parasitol Drugs Drug Resist 17:23\u201326. https:\/\/doi.org\/10.1016\/j.ijpddr.2021.06.003","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5060_CR43","unstructured":"World Health Organization, Hoffmann-La F, Roche S (1991) Review of the Central Nervous System Adverse Events Related to the Anti-malarial Drug, Mefloquine (1985\u20131990). web page. http:\/\/apps.who.int\/iris\/bitstream\/10665\/61327\/1\/WHO MAL 91.1063"},{"key":"5060_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1708-8305.1999.tb00843.x","volume":"6","author":"P Schlagenhauf","year":"1999","unstructured":"Schlagenhauf P (1999) Mefloquine for malaria chemoprophylaxis 1992\u20131998: a review. J Travel Med 6:122\u2013133. https:\/\/doi.org\/10.1111\/j.1708-8305.1999.tb00843.x","journal-title":"J Travel Med"},{"key":"5060_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4269\/ajtmh.1997.57.399","volume":"57","author":"GD Todd","year":"1997","unstructured":"Todd GD, Hopperus Buma AP, Green MD, Jaspers CA, Lobel HO (1997) Comparison of whole blood and serum levels of mefloquine and its carboxylic acid metabolite. Am J Trop Med Hyg 57:399\u2013402. https:\/\/doi.org\/10.4269\/ajtmh.1997.57.399","journal-title":"Am J Trop Med Hyg"},{"key":"5060_CR46","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s002280050523","volume":"54","author":"E Weidekamm","year":"1998","unstructured":"Weidekamm E, R\u00fcsing G, Caplain H, S\u00f6rgel F, Crevoisier C (1998) Lack of bioequivalence of a generic mefloquine tablet with the standard product. Eur J Clin Pharmacol 54:615\u2013619. https:\/\/doi.org\/10.1007\/s002280050523","journal-title":"Eur J Clin Pharmacol"},{"key":"5060_CR47","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1128\/AAC.44.4.848-852.2000","volume":"44","author":"CM Kunin","year":"2000","unstructured":"Kunin CM, Ellis WY (2000) Antimicrobial activities of mefloquine and a series of related compounds. Antimicrob Agents Chemother 44:848\u2013852. https:\/\/doi.org\/10.1128\/AAC.44.4.848-852.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"5060_CR48","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","volume":"133","author":"H-H Fan","year":"2020","unstructured":"Fan H-H, Wang L-Q, Liu W-L, An X-P, Liu Z-D, He X-Q et al (2020) Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model. Chin Med J (Engl) 133:1051\u20131056. https:\/\/doi.org\/10.1097\/CM9.0000000000000797","journal-title":"Chin Med J (Engl)"},{"key":"5060_CR49","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1128\/AAC.43.8.1870","volume":"43","author":"LE Bermudez","year":"1999","unstructured":"Bermudez LE, Kolonoski P, Wu M, Aralar PA, Inderlied CB, Young LS (1999) Mefloquine is active in vitro and in vivo against Mycobacterium avium complex. Antimicrob Agents Chemother 43:1870\u20131874. https:\/\/doi.org\/10.1128\/AAC.43.8.1870","journal-title":"Antimicrob Agents Chemother"},{"key":"5060_CR50","doi-asserted-by":"publisher","first-page":"1470891","DOI":"10.3389\/fcimb.2024.1470891","volume":"14","author":"X Liang","year":"2024","unstructured":"Liang X, Liu Z, Wang Y, Zhang Y, Deng W, Liu Q et al (2024) Progress in the study of mefloquine as an antibiotic adjuvant for combination bacterial inhibition treatment. Front Cell Infect Microbiol 14:1470891. https:\/\/doi.org\/10.3389\/fcimb.2024.1470891","journal-title":"Front Cell Infect Microbiol"},{"key":"5060_CR51","doi-asserted-by":"publisher","first-page":"790220","DOI":"10.3389\/fmicb.2021.790220","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhao Y, Feng L, Xu M, Ge Y, Wang L et al (2021) Combined with mefloquine, resurrect colistin active in colistin-resistant Pseudomonas aeruginosa in vitro and in vivo. Front Microbiol 12:790220. https:\/\/doi.org\/10.3389\/fmicb.2021.790220","journal-title":"Front Microbiol"},{"key":"5060_CR52","doi-asserted-by":"publisher","first-page":"106309","DOI":"10.1016\/j.ijantimicag.2021.106309","volume":"57","author":"Y Hu","year":"2021","unstructured":"Hu Y, Coates A (2021) Mefloquine enhances the activity of colistin against antibiotic-resistant enterobacterales in vitro and in an in vivo animal study. Int J Antimicrob Agents 57:106309. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106309","journal-title":"Int J Antimicrob Agents"},{"key":"5060_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40560-015-0072-9","volume":"3","author":"M Gurjar","year":"2015","unstructured":"Gurjar M (2015) Colistin for lung infection: an update. J Intensive Care 3:3. https:\/\/doi.org\/10.1186\/s40560-015-0072-9","journal-title":"J Intensive Care"},{"key":"5060_CR54","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/microorganisms8111716","volume":"8","author":"FF Andrade","year":"2020","unstructured":"Andrade FF, Silva D, Rodrigues A, Pina-Vaz C (2020) Colistin Update on its mechanism of Action and Resistace, Present and Future challenges. Microorganisms 8:1716. https:\/\/doi.org\/10.3390\/microorganisms8111716","journal-title":"Microorganisms"},{"key":"5060_CR55","doi-asserted-by":"publisher","first-page":"666030","DOI":"10.3389\/fcimb.2021.666030","volume":"11","author":"S Singh","year":"2021","unstructured":"Singh S, Pathak A, Rahman M, Singh A, Nag S, Sahu C et al (2021) Genetic characterisation of Colistin resistant Klebsiella pneumoniae clinical isolates from North India. Front Cell Infect Microbiol 11:666030. https:\/\/doi.org\/10.3389\/fcimb.2021.666030","journal-title":"Front Cell Infect Microbiol"},{"key":"5060_CR56","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1128\/AAC.02166-13","volume":"58","author":"GL Daikos","year":"2014","unstructured":"Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A et al (2014) Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 58:2322\u20132328. https:\/\/doi.org\/10.1128\/AAC.02166-13","journal-title":"Antimicrob Agents Chemother"},{"key":"5060_CR57","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/antibiotics9100647","volume":"9","author":"W Katip","year":"2020","unstructured":"Katip W, Uitrakul S, Oberdorfer P (2020) A comparison of Colistin versus Colistin Plus Meropenem for the treatment of Carbapenem-Resistant Acinetobacter baumannii in critically ill patients: a propensity score-matched analysis. Antibiot Basel Switz 9:647. https:\/\/doi.org\/10.3390\/antibiotics9100647","journal-title":"Antibiot Basel Switz"},{"key":"5060_CR58","doi-asserted-by":"publisher","first-page":"107338","DOI":"10.1016\/j.ijantimicag.2024.107338","volume":"64","author":"X Geng","year":"2024","unstructured":"Geng X, Li Y, Hao R, Xu C, Li Z, Yang Y et al (2024) Isobavachalcone enhances sensitivity of colistin-resistant Klebsiella pneumoniae: in vitro and in vivo proof-of-concept studies. Int J Antimicrob Agents 64:107338. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107338","journal-title":"Int J Antimicrob Agents"},{"key":"5060_CR59","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tim.2023.10.006","volume":"32","author":"J-H Liu","year":"2024","unstructured":"Liu J-H, Liu Y-Y, Shen Y-B, Yang J, Walsh TR, Wang Y et al (2024) Plasmid-mediated colistin-resistance genes: mcr. Trends Microbiol 32:365\u2013378. https:\/\/doi.org\/10.1016\/j.tim.2023.10.006","journal-title":"Trends Microbiol"},{"key":"5060_CR60","doi-asserted-by":"publisher","first-page":"38793","DOI":"10.1038\/srep38793","volume":"6","author":"M Hu","year":"2016","unstructured":"Hu M, Guo J, Cheng Q, Yang Z, Chan EWC, Chen S et al (2016) Crystal structure of Escherichia coli originated MCR-1, a phosphoethanolamine transferase for Colistin Resistance. Sci Rep 6:38793. https:\/\/doi.org\/10.1038\/srep38793","journal-title":"Sci Rep"},{"key":"5060_CR61","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1021\/acs.jcim.0c01051","volume":"60","author":"J Li","year":"2020","unstructured":"Li J, Beuerman R, Verma CS (2020) Dissecting the molecular mechanism of Colistin Resistance in mcr-1 Bacteria. J Chem Inf Model 60:4975\u20134984. https:\/\/doi.org\/10.1021\/acs.jcim.0c01051","journal-title":"J Chem Inf Model"},{"key":"5060_CR62","doi-asserted-by":"publisher","first-page":"e01191","DOI":"10.1128\/mBio.01191-16","volume":"7","author":"JR Mediavilla","year":"2016","unstructured":"Mediavilla JR, Patrawalla A, Chen L, Chavda KD, Mathema B, Vinnard C et al (2016) Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, causing a complicated urinary tract infection in a patient from the United States. mBio 7:e01191\u2013e01116. https:\/\/doi.org\/10.1128\/mBio.01191-16","journal-title":"mBio"},{"key":"5060_CR63","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/jac\/dku430","volume":"70","author":"SE Reuter","year":"2015","unstructured":"Reuter SE, Upton RN, Evans AM, Navaratnam V, Olliaro PL (2015) Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria. J Antimicrob Chemother 70:868\u2013876. https:\/\/doi.org\/10.1093\/jac\/dku430","journal-title":"J Antimicrob Chemother"},{"key":"5060_CR64","doi-asserted-by":"publisher","unstructured":"Krudsood S, Looareesuwan S, Tangpukdee N, Wilairatana P, Phumratanaprapin W, Leowattana W et al (2010) New fixed-dose artesunate-mefloquine formulation against Multidrug-Resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with Standard-Dose Nonfixed Artesunate plus Mefloquine. https:\/\/doi.org\/10.1128\/aac.01187-09. Antimicrob Agents Chemother","DOI":"10.1128\/aac.01187-09"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05060-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:54:34Z","timestamp":1746708874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05060-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["5060"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05060-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Authors had sought consent from the individual to publish the data in a journal article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors contributed to the formation of this paper\u2019s important intellectual content and reviewed and approved the final text for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}